Innovation Pharmaceuticals Inc (IPIX)

[BioTechMaven]

Essentially, 4 months away to learning if Prurisol is better than Otezla, a forecasted $2 Billion dollar drug in 2017. If you believe the small sample size of the 200mg arm in the Phase 2 trial, Prurisol has already bettered Otezla. The proof will be in the pudding and the fascinating thing is it's coming up on us very soon. I'm also watching the Brilacidin trial for UP/UC very closely. It's a tremendously huge market and it will be fascinating to see the final report for this trial. Lastly, hopeful that the Kevetrin engine fires back up into the start of its Phase 2. Three drugs, three hugely lucrative markets, chips scattered across the table. I'll be looking to add big chunks within the next 90 days, and average down a bit. Will hold majority through first partnership announcement (I'm assuming summer or fall '17), though a sharky big pharma could sneak in any time and acquire one or two drugs, or the entire company. You don't make it to Phase 2 with three drugs and not have one of them attract a suitor--not possible. Just a matter of time. I'm continuing to weight Prurisol as the heaviest near term catalyst and maintaining a valuation of $5-10B if the trial delivers anything north of 30 % at PASI 75, which I firmly believe it can and will. big pharma won't underpay Cellceutix after a stellar 2B completion, that's the sweet spot for big deal making.